The estimated Net Worth of Ventures Ii Llc Versant Ven... is at least $1.19 Millón dollars as of 17 November 2014. Ventures Ven owns over 5,343 units of Inogen Inc stock worth over $468,978 and over the last 10 years Ventures sold INGN stock worth over $719,103.
Ventures has made over 5 trades of the Inogen Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Ventures sold 5,343 units of INGN stock worth $132,987 on 17 November 2014.
The largest trade Ventures's ever made was selling 9,433 units of Inogen Inc stock on 12 November 2014 worth over $237,051. On average, Ventures trades about 3,311 units every 3 days since 2014. As of 17 November 2014 Ventures still owns at least 40,569 units of Inogen Inc stock.
You can see the complete history of Ventures Ven stock trades at the bottom of the page.
Over the last 11 years, insiders at Inogen Inc have traded over $242,179,025 worth of Inogen Inc stock and bought 9,125 units worth $253,950 . The most active insiders traders include Holdings A/S Novo, Timothy Petersen y Raymond Huggenberger. On average, Inogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $321,391. The most recent stock trade was executed by Jason Somer on 1 June 2024, trading 577 units of INGN stock currently worth $6,670.
inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take
Inogen Inc executives and other stock owners filed with the SEC include: